We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $347M
1-Year Est. Return 29.87%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
10 Year Est. Return
AUM
$166M
AUM Growth
+$1.97M
Cap. Flow
+$3.77M
Cap. Flow %
2.26%
Top 10 Hldgs %
52.32%
Holding
59
New
2
Increased
21
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$7.04M
2
HPQ icon
HP
HPQ
+$6.56M
3
INGR icon
Ingredion
INGR
+$5.8M
4
NYT icon
New York Times
NYT
+$2.13M
5
DGX icon
Quest Diagnostics
DGX
+$297K

Top Sells

Rank Stock Value
1
CSRA
CSRA Inc.
CSRA
+$6.14M
2
HPE icon
Hewlett Packard
HPE
+$5.91M
3
BUD icon
AB InBev
BUD
+$4.95M
4
WYNN icon
Wynn Resorts
WYNN
+$888K
5
CPRT icon
Copart
CPRT
+$379K

Sector Composition

Rank Sector Weight
1 Industrials 32.03%
2 Financials 16.72%
3 Consumer Discretionary 11.17%
4 Healthcare 10.52%
5 Technology 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$13.6M 8.19%
1,070,340
-32,740
-3% -$379K
AGM icon
2
Federal Agricultural Mortgage
AGM
$2.27B
$10.4M 6.24%
119,410
+130
+0.1% +$10.5K
DE icon
3
Deere & Co
DE
$170B
$9.4M 5.65%
60,534
-708
-1% -$115K
GD icon
4
General Dynamics
GD
$105B
$8.87M 5.33%
40,162
+335
+0.8% +$72.9K
INGR icon
5
Ingredion
INGR
$6.38B
$8.68M 5.22%
67,359
+43,359
+181% +$5.8M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.07T
$8.65M 5.2%
43,352
-130
-0.3% -$26.7K
JNJ icon
7
Johnson & Johnson
JNJ
$635B
$7.65M 4.6%
59,713
+39
+0.1% +$5.27K
COF icon
8
Capital One
COF
$124B
$6.73M 4.04%
70,243
+214
+0.3% +$21.3K
APTV icon
9
Aptiv
APTV
$12B
$6.59M 3.96%
+77,595
New +$7.04M
FMC icon
10
FMC
FMC
$1.42B
$6.48M 3.89%
97,512
+2,493
+3% +$186K
KEYS icon
11
Keysight
KEYS
$54.5B
$6.38M 3.83%
121,795
+2,390
+2% +$114K
HPQ icon
12
HP
HPQ
$23.5B
$6.37M 3.83%
+290,600
New +$6.56M
CNI icon
13
Canadian National Railway
CNI
$78.3B
$6.3M 3.79%
86,161
+2,108
+3% +$163K
CMI icon
14
Cummins
CMI
$91.7B
$6.28M 3.77%
38,720
+641
+2% +$110K
TJX icon
15
TJX Companies
TJX
$170B
$6.21M 3.73%
152,156
+3,980
+3% +$157K
MIDD icon
16
Middleby
MIDD
$6.05B
$5.31M 3.19%
42,916
+1,575
+4% +$206K
CL icon
17
Colgate-Palmolive
CL
$72.6B
$4.77M 2.87%
66,552
+1,281
+2% +$92.2K
NYT icon
18
New York Times
NYT
$11.6B
$4.68M 2.81%
194,120
+92,570
+91% +$2.13M
PII icon
19
Polaris
PII
$4.15B
$4.58M 2.75%
40,030
+880
+2% +$106K
LH icon
20
Labcorp
LH
$24.3B
$4.44M 2.67%
31,979
+638
+2% +$93.7K
DGX icon
21
Quest Diagnostics
DGX
$25.1B
$4.05M 2.43%
40,389
+2,897
+8% +$297K
TCP
22
DELISTED
TC Pipelines LP
TCP
$3.45M 2.07%
99,423
+357
+0.4% +$17.6K
JKHY icon
23
Jack Henry & Associates
JKHY
$10.7B
$2.59M 1.55%
21,389
-89
-0.4% -$10.8K
XOM icon
24
ExxonMobil
XOM
$651B
$1.88M 1.13%
25,168
-2,245
-8% -$179K
AAPL icon
25
Apple
AAPL
$4.89T
$830K 0.5%
19,776
-200
-1% -$8.61K

Similar funds

Weybosset Research & Management's Q1 2018 Portfolio in Review

As of Q1 2018, Weybosset Research & Management held 59 positions worth $166M, up 1.2% from $164M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Weybosset Research & Management's Q1 2018 filing shows 2 new, 21 increased, 24 reduced and 5 closed positions. Its largest new stake was Aptiv: 77,595 shares worth $6.59M. The largest sale was CSRA Inc., an estimated $6.14M.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Weybosset Research & Management's largest Q1 2018 buy was Aptiv: 77,595 shares worth $6.59M.
  • Weybosset Research & Management added most to Ingredion in Q1 2018, an estimated $5.8M increase.
  • Weybosset Research & Management's biggest Q1 2018 reduction was Copart, cutting an estimated $379K.
  • Weybosset Research & Management fully exited CSRA Inc. in Q1 2018, selling an estimated $6.14M.
  • Weybosset Research & Management's ten largest holdings make up 52% of its $166M portfolio in Q1 2018.
  • Weybosset Research & Management opened 2 new positions and closed 5 in Q1 2018.
  • Weybosset Research & Management's portfolio value rose 1.2% quarter-over-quarter to $166M.

Based on Weybosset Research & Management's 13F filing for Q1 2018, filed 2 May 2018.